X4 Pharmaceuticals Stock Price on September 16, 2024
| XFOR Stock | USD 0.67 0 0.45% |
Below is the normalized historical share price chart for X4 Pharmaceuticals extending back to November 16, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of X4 Pharmaceuticals stands at 0.67, as last reported on the 11th of December 2024, with the highest price reaching 0.67 and the lowest price hitting 0.67 during the day.
If you're considering investing in XFOR Stock, it is important to understand the factors that can impact its price. X4 Pharmaceuticals appears to be abnormally volatile, given 3 months investment horizon. X4 Pharmaceuticals retains Efficiency (Sharpe Ratio) of 0.0606, which attests that the company had a 0.0606% return per unit of price deviation over the last 3 months. By inspecting X4 Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please utilize X4 Pharmaceuticals' market risk adjusted performance of 31.43, and Standard Deviation of 11.19 to validate if our risk estimates are consistent with your expectations.
At this time, X4 Pharmaceuticals' Common Stock Total Equity is relatively stable compared to the past year. As of 12/11/2024, Common Stock Shares Outstanding is likely to grow to about 186.7 M, while Liabilities And Stockholders Equity is likely to drop slightly above 102.4 M. . At this time, X4 Pharmaceuticals' Price To Sales Ratio is relatively stable compared to the past year. As of 12/11/2024, Price Book Value Ratio is likely to grow to 3.06, while Price To Operating Cash Flows Ratio is likely to drop (1.62). XFOR Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of November 2017 | 200 Day MA 0.8113 | 50 Day MA 0.4884 | Beta 0.388 |
XFOR |
Sharpe Ratio = 0.0606
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | XFOR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.45 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.69 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average X4 Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of X4 Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 1.5101 | Enterprise Value Ebitda 1.1003 | Price Sales 203.9888 | Shares Float 127.8 M | Wall Street Target Price 2.6843 |
Related Headline
Mereo BioPharma Headline on 16th of September 2024
Disposition of 75000 shares by Hughes-wilson Alexandra of Me... by news.google.com
Filed transaction by Mereo BioPharma Group Officer: See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
X4 Pharmaceuticals Valuation on September 16, 2024
It is possible to determine the worth of X4 Pharmaceuticals on a given historical date. On September 16, 2024 XFOR was worth 0.7 at the beginning of the trading date compared to the closed value of 0.66. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of X4 Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find X4 Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of X4 Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against X4 Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.69 | 0.71 | 0.67 | 0.71 | 773,395 | |
09/16/2024 | 0.70 | 0.74 | 0.64 | 0.66 | 966,757 |
| 0.67 | 0.71 | 0.66 | 0.70 | 665,805 |
| Backtest X4 Pharmaceuticals | | | X4 Pharmaceuticals History | | | X4 Pharmaceuticals Valuation | Previous | Next |
X4 Pharmaceuticals Trading Date Momentum on September 16, 2024
| On September 17 2024 X4 Pharmaceuticals was traded for 0.70 at the closing time. The top price for the day was 0.71 and the lowest listed price was 0.66 . The trading volume for the day was 665.8 K. The trading history from September 17, 2024 was a factor to the next trading day price gain. The trading price change against the next closing price was 6.06% . The trading price change against the current closing price is 0.00% . |
X4 Pharmaceuticals Fundamentals Correlations and Trends
By evaluating X4 Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among X4 Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. XFOR financial account trend analysis is a perfect complement when working with valuation or volatility modules.About X4 Pharmaceuticals Stock history
X4 Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XFOR is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in X4 Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing X4 Pharmaceuticals stock prices may prove useful in developing a viable investing in X4 Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 177.8 M | 186.7 M | |
| Net Loss | -86.8 M | -82.4 M |
X4 Pharmaceuticals Quarterly Net Working Capital |
|
X4 Pharmaceuticals Stock Technical Analysis
X4 Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
X4 Pharmaceuticals Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
X4 Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
X4 Pharmaceuticals December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how X4 Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading X4 Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying X4 Pharmaceuticals stock market strength indicators, traders can identify X4 Pharmaceuticals entry and exit signals to maximize returns
X4 Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for X4 Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of XFOR Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XFOR to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0536 | |||
| Jensen Alpha | 0.6731 | |||
| Total Risk Alpha | (1.10) | |||
| Sortino Ratio | 0.0437 | |||
| Treynor Ratio | 31.42 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for XFOR Stock Analysis
When running X4 Pharmaceuticals' price analysis, check to measure X4 Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy X4 Pharmaceuticals is operating at the current time. Most of X4 Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of X4 Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move X4 Pharmaceuticals' price. Additionally, you may evaluate how the addition of X4 Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.